Ushio (6925) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
9 Sep, 2026Executive summary
H1 FY2025 net sales declined 4.9% YoY to ¥81.4B, operating profit fell 6.0% to ¥4.0B, and net profit dropped 89.6% to ¥0.2B, but results exceeded internal forecasts due to early DLT system sales and structural reforms.
The global economy remained uncertain due to U.S. tariffs, Chinese trends, exchange rates, and geopolitical risks, impacting demand and investment across key markets.
Strategic investments in DLT and lithography equipment increased as planned, with business portfolio revamp initiatives progressing.
Financial highlights
H1 FY2025 net sales: ¥81.4B, down ¥4.2B (-4.9%) YoY; operating profit: ¥4.0B, down ¥0.2B (-6.0%) YoY; net profit: ¥0.2B, down ¥2.0B (-89.6%) YoY.
EPS fell to ¥2.77 from ¥22.95 YoY; operating margin was 4.9%.
Gross profit for the period was ¥29.6B, down from ¥31.0B YoY.
Ordinary profit decreased 7.6% to ¥5.0B; comprehensive income improved to ¥4.4B from a loss of ¥4.0B a year earlier.
Extraordinary loss of ¥4.0B from business restructuring, partially offset by ¥1.8B gain on sales of cross-shareholdings.
Outlook and guidance
FY2025 full-year forecasts unchanged: net sales ¥170.0B, operating profit ¥10.0B (+13.3% YoY), EPS ¥79.45 (+13.1% YoY).
Delayed full-scale ramp-up of DLT systems factored in; no additional impact from U.S. tariffs.
Dividend forecast unchanged at ¥70/share through FY2026; ongoing share buybacks planned.
Latest events from Ushio
- Profits and sales fell sharply, but guidance and dividend forecasts remain unchanged.6925
Q1 2025 - Net sales grew 0.8% but profits fell sharply; full-year profit outlook revised upward.6925
Q2 2025 - Profits and sales fell but exceeded forecasts; dividend and buybacks increased.6925
Q3 2025 - Operating profit dropped 32% on lower sales and inventory write-downs, but cash flow improved.6925
Q4 2025 - Net loss despite higher sales, with lamp business acquisition to support future growth.6925
Q1 2026 - Profits and sales rose, with strong Visual Imaging gains and a positive FY2026 outlook.6925
Q4 2026 - Operating profit rose despite lower sales, with strong gains in Visual Imaging and Life Sciences.6925
Q3 2026